{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:42Z","timestamp":1787020362976,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02168-3","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T17:03:43Z","timestamp":1768669423000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between albumin-bilirubin (ALBI) score and metabolically healthy obesity among US adults: findings from NHANES 2005\u20132018"],"prefix":"10.1186","volume":"26","author":[{"given":"Chenyi","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"25","key":"2168_CR1","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","volume":"381","author":"ZJ Ward","year":"2019","unstructured":"Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. State-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381(25):2440\u201350.","journal-title":"N Engl J Med"},{"key":"2168_CR2","doi-asserted-by":"crossref","unstructured":"Ziolkowska S, Binienda A, Jab\u0142kowski M, Szemraj J, Czarny P. The interplay between insulin resistance, inflammation, oxidative stress, base excision repair and metabolic syndrome in nonalcoholic fatty liver disease. Int J Mol Sci. 2021;22(20).","DOI":"10.3390\/ijms222011128"},{"issue":"7","key":"2168_CR3","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1097\/HJH.0000000000001730","volume":"36","author":"V Kotsis","year":"2018","unstructured":"Kotsis V, Jordan J, Micic D, Finer N, Leitner DR, Toplak H, et al. Obesity and cardiovascular risk: a call for action from the European society of hypertension working group of obesity, diabetes and the high-risk patient and European association for the study of obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment. J Hypertens. 2018;36(7):1427\u201340.","journal-title":"J Hypertens"},{"issue":"11","key":"2168_CR4","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/dme.14356","volume":"37","author":"TJ Hydes","year":"2020","unstructured":"Hydes TJ, Summers N, Brown E, Alam U, Thomaides-Brears H, Wilding JPH, et al. Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes. Diabet Med. 2020;37(11):1793\u2013806.","journal-title":"Diabet Med"},{"key":"2168_CR5","doi-asserted-by":"crossref","unstructured":"Brant LC, Wang N, Ojeda FM, LaValley M, Barreto SM, Benjamin EJ, et al. Relations of metabolically healthy and unhealthy obesity to digital vascular function in three community-based cohorts: a meta-analysis. J Am Heart Assoc. 2017;6(3).","DOI":"10.1161\/JAHA.116.004199"},{"issue":"10","key":"2168_CR6","doi-asserted-by":"publisher","first-page":"e1003351","DOI":"10.1371\/journal.pmed.1003351","volume":"17","author":"M Gao","year":"2020","unstructured":"Gao M, Lv J, Yu C, Guo Y, Bian Z, Yang R, et al. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: a cohort study. PLoS Med. 2020;17(10):e1003351.","journal-title":"PLoS Med"},{"issue":"2","key":"2168_CR7","doi-asserted-by":"publisher","first-page":"e 3766","DOI":"10.1002\/dmrr.3766","volume":"40","author":"Q Huang","year":"2024","unstructured":"Huang Q, Liu Z, Wei M, Feng J, Huang Q, Liu Y, et al. Metabolically healthy obesity, transition from metabolic healthy to unhealthy status, and carotid atherosclerosis. Diabetes Metab Res Rev. 2024;40(2):e 3766.","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"2168_CR8","doi-asserted-by":"publisher","first-page":"e232145","DOI":"10.1001\/jamanetworkopen.2023.2145","volume":"6","author":"JS Wang","year":"2023","unstructured":"Wang JS, Xia PF, Ma MN, Li Y, Geng TT, Zhang YB, et al. Trends in the prevalence of metabolically healthy obesity among US adults, 1999-2018. JAMA Netw Open. 2023;6(3):e232145.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2168_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12933-023-01815-6","volume":"22","author":"D Wei","year":"2023","unstructured":"Wei D, Gonz\u00e1lez-Marrachelli V, Melgarejo JD, Liao CT, Hu A, Janssens S, et al. Cardiovascular risk of metabolically healthy obesity in two European populations: prevention potential from a metabolomic study. Cardiovasc Diabetol. 2023;22(1):82.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"2168_CR10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/ijo.2017.233","volume":"42","author":"AE Espinosa De Ycaza","year":"2018","unstructured":"Espinosa De Ycaza AE, Donegan D, Jensen MD. Long-term metabolic risk for the metabolically healthy overweight\/obese phenotype. Int J Obes (Lond). 2018;42(3):302\u201309.","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"2168_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3803\/EnM.2019.34.4.406","volume":"34","author":"JA Kim","year":"2019","unstructured":"Kim JA, Kim DH, Kim SM, Park YG, Kim NH, Baik SH, et al. Impact of the dynamic change of metabolic health status on the incident type 2 diabetes: a nationwide population-based cohort study. Endocrinol Metab (Seoul). 2019;34(4):406\u201314.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"9","key":"2168_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","volume":"6","author":"N Eckel","year":"2018","unstructured":"Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses\u2019 Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6(9):714\u201324.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2168_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/nyas.13230","volume":"1391","author":"CM Phillips","year":"2017","unstructured":"Phillips CM. Metabolically healthy obesity across the life course: epidemiology, determinants, and implications. Ann N Y Acad Sci. 2017;1391(1):85\u2013100.","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"2168_CR14","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s00125-021-05484-6","volume":"64","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Macpherson J, Gray SR, Gill JMR, Welsh P, Celis-Morales C, et al. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381, 363 UK biobank participants. Diabetologia. 2021;64(9):1963\u201372.","journal-title":"Diabetologia"},{"key":"2168_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejim.2023.02.025","volume":"111","author":"C Tanriover","year":"2023","unstructured":"Tanriover C, Copur S, Gaipov A, Ozlusen B, Akcan RE, Kuwabara M, et al. Metabolically healthy obesity: Misleading phrase or healthy phenotype? Eur J Intern Med. 2023;111:5\u201320.","journal-title":"Eur J Intern Med"},{"issue":"1","key":"2168_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40519-025-01717-4","volume":"30","author":"Y Cui","year":"2025","unstructured":"Cui Y, Cheng Z. Exploring the mediating role of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) in the association between obesity and sleep-disordered breathing. Eat Weight Disord. 2025;30(1):11.","journal-title":"Eat Weight Disord"},{"issue":"5","key":"2168_CR17","doi-asserted-by":"publisher","first-page":"100347","DOI":"10.1016\/j.jhepr.2021.100347","volume":"3","author":"CO Demirtas","year":"2021","unstructured":"Demirtas CO, D\u2019Alessio A, Rimassa L, Sharma R, Pinato DJ. ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma. JHEP Rep. 2021;3(5):100347.","journal-title":"JHEP Rep"},{"issue":"10","key":"2168_CR18","doi-asserted-by":"publisher","first-page":"100557","DOI":"10.1016\/j.jhepr.2022.100557","volume":"4","author":"H Toyoda","year":"2022","unstructured":"Toyoda H, Johnson PJ. The ALBI score: from liver function in patients with HCC to a general measure of liver function. JHEP Rep. 2022;4(10):100557.","journal-title":"JHEP Rep"},{"issue":"9","key":"2168_CR19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3748\/wjg.v30.i9.999","volume":"30","author":"SX Xu","year":"2024","unstructured":"Xu SX, Yang F, Ge N, Guo JT, Sun SY. Role of albumin-bilirubin score in non-malignant liver disease. World J Gastroenterol. 2024;30(9):999\u20131004.","journal-title":"World J Gastroenterol"},{"issue":"46","key":"2168_CR20","doi-asserted-by":"publisher","first-page":"6089","DOI":"10.3748\/wjg.v29.i46.6089","volume":"29","author":"A Pasta","year":"2023","unstructured":"Pasta A, Calabrese F, Plaz Torres MC, Bodini G, Furnari M, Savarino EV, et al. Albumin-bilirubin score in non-malignant liver diseases should be properly validated. World J Gastroenterol. 2023;29(46):6089\u201391.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"2168_CR21","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","volume":"3","author":"H Tilg","year":"2021","unstructured":"Tilg H, Adolph TE, Dudek M, Knolle P. Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. Nat Metab. 2021;3(12):1596\u2013607.","journal-title":"Nat Metab"},{"issue":"4","key":"2168_CR22","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.aohep.2020.03.001","volume":"19","author":"A Lonardo","year":"2020","unstructured":"Lonardo A, Mantovani A, Lugari S, Targher G. Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity. Ann Hepatol. 2020;19(4):359\u201366.","journal-title":"Ann Hepatol"},{"key":"2168_CR23","doi-asserted-by":"crossref","unstructured":"Cernea S. NAFLD fibrosis progression and type 2 diabetes: the hepatic-metabolic interplay. Life (Basel). 2024;14(2).","DOI":"10.3390\/life14020272"},{"issue":"1","key":"2168_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY. Inflammation in obesity, diabetes, and related disorders. Immunity. 2022;55(1):31\u201355.","journal-title":"Immunity"},{"key":"2168_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397.","journal-title":"Metabolism"},{"issue":"12","key":"2168_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1080\/01616412.2024.2403858","volume":"46","author":"L Huang","year":"2024","unstructured":"Huang L, Chen Y, Sun J, Xu L. Exploring the correlation between dietary zinc intake and stroke risk in adults based on NHANES database. Neurol Res. 2024;46(12):1113\u201321.","journal-title":"Neurol Res"},{"issue":"6","key":"2168_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550\u201358.","journal-title":"J Clin Oncol"},{"issue":"41","key":"2168_CR28","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.3748\/wjg.v30.i41.4481","volume":"30","author":"LF Zhang","year":"2024","unstructured":"Zhang LF, Chen LX, Yang WJ, Hu B. Albumin-bilirubin score in non-malignant liver and other diseases. World J Gastroenterol. 2024;30(41):4481\u201383.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2168_CR29","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.surge.2019.09.002","volume":"18","author":"M Deng","year":"2020","unstructured":"Deng M, Ng SWY, Cheung ST, Chong CCN. Clinical application of albumin-bilirubin (ALBI) score: the current status. Surgeon. 2020;18(3):178\u201386.","journal-title":"Surgeon"},{"issue":"1","key":"2168_CR30","doi-asserted-by":"publisher","first-page":"2403721","DOI":"10.1080\/07853890.2024.2403721","volume":"56","author":"Z Li","year":"2024","unstructured":"Li Z, Yao Z, Liu Q. Association of serum calcium and metabolically healthy obese in US adults: a cross-sectional study. Ann Med. 2024;56(1):2403721.","journal-title":"Ann Med"},{"key":"2168_CR31","doi-asserted-by":"publisher","first-page":"1460057","DOI":"10.3389\/fnut.2024.1460057","volume":"11","author":"J Jiang","year":"2024","unstructured":"Jiang J, Zhao H, Chen J, Du J, Ni W, Zheng B, et al. The association between dietary creatine intake and cancer in U.S. adults: insights from NHANES 2007-2018. Front Nutr. 2024;11:1460057.","journal-title":"Front Nutr"},{"issue":"1","key":"2168_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12888-021-03275-2","volume":"21","author":"YY Shi","year":"2021","unstructured":"Shi YY, Zheng R, Cai JJ, Qian SZ. The association between triglyceride glucose index and depression: data from NHANES 2005-2018. BMC Psychiatry. 2021;21(1):267.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"2168_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"2168_CR34","doi-asserted-by":"publisher","first-page":"e062651","DOI":"10.1136\/bmjopen-2022-062651","volume":"12","author":"Y Wen","year":"2022","unstructured":"Wen Y, Liu T, Li S, Gong R, Li C. Trends in the prevalence of metabolically healthy and unhealthy obesity in the US adult population: analysis of eight NHANES cross-sectional survey cycles, 1999-2014. BMJ Open. 2022;12(11):e062651.","journal-title":"BMJ Open"},{"key":"2168_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.metabol.2019.05.002","volume":"97","author":"YK Cho","year":"2019","unstructured":"Cho YK, Kang YM, Yoo JH, Lee J, Park JY, Lee WJ, et al. Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study. Metabolism. 2019;97:50\u201356.","journal-title":"Metabolism"},{"key":"2168_CR36","doi-asserted-by":"publisher","first-page":"625083","DOI":"10.3389\/fendo.2021.625083","volume":"12","author":"HS Kim","year":"2021","unstructured":"Kim HS, Lee J, Cho YK, Park JY, Lee WJ, Kim YJ, et al. Differential effect of metabolic health and obesity on incident heart failure: a nationwide population-based cohort study. Front Endocrinol (Lausanne). 2021;12:625083.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2168_CR37","doi-asserted-by":"crossref","unstructured":"Bl\u00fcher M. Metabolically healthy obesity. Endocr Rev. 2020;41(3).","DOI":"10.1210\/endrev\/bnaa004"},{"issue":"2","key":"2168_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s13679-020-00375-0","volume":"9","author":"A Tsatsoulis","year":"2020","unstructured":"Tsatsoulis A, Paschou SA. Metabolically healthy obesity: criteria, epidemiology, controversies, and consequences. Curr Obes Rep. 2020;9(2):109\u201320.","journal-title":"Curr Obes Rep"},{"key":"2168_CR39","doi-asserted-by":"publisher","first-page":"1458764","DOI":"10.3389\/fnut.2025.1458764","volume":"12","author":"Z Li","year":"2025","unstructured":"Li Z, Yao Z, Liu Q. The association between white blood cell counts and metabolic health obesity among US adults. Front Nutr. 2025;12:1458764.","journal-title":"Front Nutr"},{"issue":"6","key":"2168_CR40","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.numecd.2023.03.020","volume":"33","author":"AM Netto","year":"2023","unstructured":"Netto AM, Kashiwagi NM, Minanni CA, Santos RD, Cesena FY. Adiposity, hepatic steatosis, and metabolic health transitions in people with obesity: influences of age and sex. Nutr Metab Cardiovasc Dis. 2023;33(6):1149\u201357.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2168_CR41","doi-asserted-by":"crossref","unstructured":"Baek SU, Yoon JH. Systemic inflammation across metabolic obesity phenotypes: a cross-sectional study of Korean adults using high-sensitivity C-Reactive protein as a biomarker. Int J Mol Sci. 2024;25(21).","DOI":"10.3390\/ijms252111540"},{"issue":"6","key":"2168_CR42","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s12072-022-10395-8","volume":"16","author":"S Man","year":"2022","unstructured":"Man S, Lv J, Yu C, Deng Y, Yin J, Wang B, et al. Association between metabolically healthy obesity and non-alcoholic fatty liver disease. Hepatol Int. 2022;16(6):1412\u201323.","journal-title":"Hepatol Int"},{"issue":"11\u201312","key":"2168_CR43","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/apt.15015","volume":"48","author":"J Ampuero","year":"2018","unstructured":"Ampuero J, Aller R, Gallego-Dur\u00e1n R, Banales JM, Crespo J, Garc\u00eda-Monz\u00f3n C, et al. The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity. Aliment Pharmacol Ther. 2018;48(11\u201312):1260\u201370.","journal-title":"Aliment Pharmacol Ther"},{"key":"2168_CR44","doi-asserted-by":"crossref","unstructured":"Anastasopoulos NA, Charchanti AV, Barbouti A, Mastoridou EM, Goussia AC, Karampa AD, et al. The role of oxidative stress and cellular senescence in the pathogenesis of metabolic associated fatty liver disease and related hepatocellular carcinoma. Antioxid (Basel). 2023;12(6).","DOI":"10.3390\/antiox12061269"},{"key":"2168_CR45","doi-asserted-by":"publisher","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","volume":"176","author":"S Kumar","year":"2021","unstructured":"Kumar S, Duan Q, Wu R, Harris EN, Su Q. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. Adv Drug Deliv Rev. 2021;176:113869.","journal-title":"Adv Drug Deliv Rev"},{"key":"2168_CR46","doi-asserted-by":"publisher","first-page":"1150118","DOI":"10.3389\/fendo.2023.1150118","volume":"14","author":"SJ Park","year":"2023","unstructured":"Park SJ, Garcia Diaz J, Um E, Hahn YS. Major roles of kupffer cells and macrophages in NAFLD development. Front Endocrinol (Lausanne). 2023;14:1150118.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2168_CR47","doi-asserted-by":"publisher","first-page":"e13236","DOI":"10.1111\/eci.13236","volume":"50","author":"S Ministrini","year":"2020","unstructured":"Ministrini S, Montecucco F, Sahebkar A, Carbone F. Macrophages in the pathophysiology of NAFLD: the role of sex differences. Eur J Clin Invest. 2020;50(6):e13236.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"2168_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.hbpd.2022.03.009","volume":"21","author":"JH Huh","year":"2022","unstructured":"Huh JH, Kim KJ, Kim SU, Cha BS, Lee BW. Obesity is an important determinant of severity in newly defined metabolic dysfunction-associated fatty liver disease. Hepatobiliary Pancreat Dis Int. 2022;21(3):241\u201347.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"2","key":"2168_CR49","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.orcp.2024.02.007","volume":"18","author":"S Man","year":"2024","unstructured":"Man S, Deng Y, Ma Y, Yang X, Wang X, Fu J, et al. Association between weight change, waist circumference change, and the risk of nonalcoholic fatty liver disease in individuals with metabolically healthy overweight or obesity and metabolically unhealthy overweight or obesity. Obes Res Clin Pract. 2024;18(2):109\u201317.","journal-title":"Obes Res Clin Pract"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02168-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02168-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:02:40Z","timestamp":1770840160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02168-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2168"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02168-3","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Health and Nutrition Examination Survey protocol was approved by the National Center for Health Statistics Research Ethics Review Board, which belongs to the National Center for Health Statistics, Centers for Disease Control and Prevention. All NHANES study protocols adhered to the Declaration of Helsinki, and written informed consent was obtained from all participants. This study utilized de-identified, publicly available NHANES data, and therefore, further institutional review board approval was not required from our institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}